Paul is a registered Australian and UK pharmacist.  His company Health House was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Over the last 30 years he has owned several retail pharmacies and worked both in Australia and the UK. In the last 3 years he has focussed on researching medicinal cannabis and has been to conferences, grow and manufacturing facilities and spoken to patients and prescribers in the US, Canada, Israel and recently South America. www.healthhouse.com.au

Sharlene is a Medical Scientist (BAppSc -Medical Laboratory Science) and director of Medical Cannabis Research Australia who has been researching how Medical Cannabis may treat an ever-increasing array of disorders. Her university background in diagnostic pathology gives her the knowledge to understand disease processes in the human body. 

She’s travelled to the US, Canada, Israel, Colombia and Chile to learn firsthand from the leading researchers in this new field of cannabinoid science. She’s passionate about sharing this knowledge by educating others under the banner of her charity Medical Cannabis Research Australia. She is committed to advocating for use and access to medical cannabis for patients in Australia as well as promoting more research to give clinicians the evidence they require to pursue this treatment for their patients, both in Australia and in the rest of the world.

FRACGP FRNZCUCP FRNZCGP BHB MBChB PGDipSpMed PGDipCEM

Director of Cannabis Doctors Australia and CDA Health Educator, Advocate and Presciber of Medicinal Cannabis

It was James' passion for the environment that led to his first involvement in industrial hemp in 2009. His interest in all aspects of industrial hemp soon expanded and he has addressed many forums on the benefits of hemp for the economy, the environment, as food and as medicine.

James is the President of the Industrial Hemp Association of NSW, an organisation whose members have been prime movers in the legalisation of hemp as food. He is President of the Australian Industrial Hemp Alliance (AIHA) a national organisation representing members from all Australian states. He is also the Chair of the AIHA sub-committee on medicinal cannabis. 

Frank Giampieri has been working in the natural medicine space for almost a decade.  After many years working as an award-winning Pastry Chef, a serious neck injury caused early retirement and much pain. Searching for alternatives to potentially addictive and dangerous drugs for pain relief was high on the agenda. After much study and trials, he was able to create safe non-addictive products that gave much needed relief of his pain. Concentrating on the endocannabinoid system and the balance and relief it can bring to the body.

Over the last 4 years Frank has been working with Doctors, Specialists and Pharmacists, offering his natural products to treat patients and obtaining outstanding results. Leading to the creation of the entourage range.

Frank is at the forefront of Terpene based medicines creating products that interact with our body to bring relief from many common ailments.

Frank is currently gaining a diploma in cannabis medicine from The Cannabis Training University.

Adam studied Entrepreneurship at the Royal Melbourne Institute of Technology and Sweden's Jönköping University for international business and completed his bachelors in 2009. Over the past eight years, Adam has worked in multiple startups with a specific focus on education and community building technology.

In 2015, Adam became involved in the medical cannabis space due to his passion for the medicine and belief in innovation stimulating its growth. In 2016, Adam founded BuddingTech, Australia’s first medical cannabis advisory firm.

As CEO of BuddingTech, Adam has worked tirelessly developing networks and collaborations, including the facilitation and management of three student research projects on medical cannabis in conjunction with the University of Sydney Business School and MGC Pharmaceuticals, publishing Australia’s first Medical Cannabis White Paper.

Additionally, Adam also founded the Medical Cannabis Council, Australia's first national industry body to represent the medical cannabis industry in Australia. The Mission of the Medical Cannabis Council is to create a unifying voice for the medical cannabis industry in Australia, facilitating a framework of best practice and supporting the positioning of Australia as a world leader in research and production of safe, scientifically backed medical cannabis products.

Adam also works with Pharmacare, the largest private, Australian-owned consumer health, fitness, and consumer goods company in the country. The company is 100% Australian and family-owned, with offices located in Australia, Canada, US, United Kingdoms, China, Thailand, Singapore, Indonesia, Malaysia and New Zealand. Acting as the Cannabis Business Manager, Adam primary objective is to build a cannabis pipeline of products for the companies local and international distribution network.

Adam has also helped coordinate a series of medical cannabis conferences across Australia, most recently, Adam assisted with coordinating Australias largest medical cannabis in Sydney. Adam has spoken at several international events and has appeared in several major news outlets including the Sydney Morning Herald, Startup Smart, SBS, SkyNews, MJBizDaily, and other major publications.

Tom Forrest CF - 2018 Churchill Fellow - is an Australian certified horticulturalist working in the protected cropping industry. Working with multiple groups including ASX public cannabis companies, universities and private businesses, Tom has helped instigate and guide multiple medical cannabis projects in Australia and New Zealand.

Tom co-founded Indicated Technology which also provides agronomist consulting and agricultural equipment procurement services to licensed cultivators throughout Asia-pacific, and multiple LPs in Canada and the USA.

Recently Tom has been speaking at pharmaceutical events, universities and worldwide conferences to share the findings of his Churchill Fellowship and provide a global overview of cannabis agronomy.  

“I was fortunate to visit 8 countries, 28 cities and around 50 cannabis cultivation sites between April and August 2019. This included visits to hi-tech sealed environment glasshouses, ‘pharma’ grade indoor facilities, traditional glasshouses, organic and outdoor broad-acre cannabis cultivation sites. The purpose of this trip was to learn from existing worldwide approaches to cannabis agronomy, and share this knowledge to help our local industry grow successfully."

School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong;

The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE)

Dr Katrina Green is a medical sciences lecturer in the School of Medicine, University of Wollongong. She is also a scientific affiliate of ACRE, the Australian Federal Government funded cannabinoid research centre that conducts collaborative research across the broad fields of plant sciences, pre-clinical and clinical research, and health policy and practice.

Dr Green has 13 years of cannabinoid medical research experience and leads a vibrant lab team who are developing new therapeutic approaches to treating illnesses of the brain. She has a keen interest in the benefits of cannabidiol (CBD) and other compounds found in hemp plants, eg terpenes and flavonoids, as well as their interactions (the ‘entourage effect’). She will present on her recent publication “The United Chemicals of Cannabis” (http://bit.ly/2UVWZ8w), which examines scientific evidence showing that certain cannabis compounds can improve brain health. Her talk will highlight the potential of hemp plants to enable the discovery of new medicines in this area.